# HARDENING REPORT

**PR:** #3 — Build Autonomous Healthcare Research & Innovation Agent layer  
**Branch:** `claude/healthcare-research-innovation-lab-l6edy0`  
**Scope:** hardening only; existing UI preserved.

## Executive verdict

**Current classification: RESEARCH-PROTOTYPE.**

The system has crossed the boundary from a prompt-only methodology into a small executable, model-agnostic research-runtime foundation. It is **not Production Ready** and should not be represented as such.

## What is executable now

1. **Capability-first Tool Adapter runtime** — adapters register by capability; health probes are executed; only a successful non-destructive probe marks a tool available; primary/fallback routing is explicit; degradation and provenance are returned with results.
2. **Bounded Research State Machine** — canonical ordered states, retry limits, circular-transition rejection, failure state, iteration bound, and human-gate state are implemented.
3. **Canonical Evidence Ledger model** — structured `Claim` objects enforce the required provenance-bearing fields; Markdown remains a presentation view. A JSON Schema is provided under `schemas/evidence-ledger.schema.json`.
4. **Ordinal Confidence Engine** — quality, consistency, directness, precision and replication are explicit dimensions; penalties exist for risk of bias, missing full text, source degradation, contradiction and indirectness. No false numeric precision is claimed.
5. **Provenance Graph** — the requested edge vocabulary is executable and validated.
6. **Human Gates** — clinical, regulatory and Go/No-Go decisions are represented as pending human decisions; rejected gates block approval.
7. **Safety validators** — fabricated/unverified identifiers, protocol-as-results, unsupported recommendations and missing human gates are rejected.
8. **Automated invariant tests** — tests cover unavailable tools, fallback, fabricated identifiers, protocol/results separation, conflict penalty, circular loop, missing provenance, unsupported recommendation and human-gate violation.
9. **CI definition** — GitHub Actions workflow is present to execute the invariant suite on branch pushes / PRs.

## What remains prompt-governed or integration-governed

- Live PubMed / ClinicalTrials.gov / WebSearch adapters are **not implemented inside this repository as network clients**. The runtime is ready to host adapters, but live tool execution remains dependent on the host agent/tool environment.
- The existing Claude Code skill remains the primary invocation surface; portability is now contractual, not yet proven by a second independent runtime.
- Screening, critical appraisal, extraction, contradiction synthesis, Saudi applicability, innovation generation and validation planning remain primarily protocol/agent logic. They are not independently validated deterministic engines.
- The existing 2026-09-07 E2E evidence set remains an abstract-only research artifact; hardening does not retroactively make those claims stronger.
- CI execution could not be independently observed from the current connector session after the workflow commit; no successful run is claimed without a returned run record.

## Evidence / E2E continuity

The existing virtual/remote nursing + heart-failure investigation remains the reference E2E case. Its ledger contains 9 claims, including explicit handling of conflicting syntheses and a protocol-only TIM-HF2 record. The prior ledger states that Elicit, Consensus and Scite were unavailable/degraded in that session and that all study rows were abstract-only. Those limitations remain material.

### Required E2E report fields

- **Tool capability status:** must be derived from live adapter probes, never configuration.
- **Evidence coverage:** current reference set covers systematic reviews, RCT/pilot evidence, a protocol, a Saudi descriptive study and a live trial-registry signal; it is not exhaustive.
- **Limitations:** abstract-only appraisal, heterogeneous telemonitoring definitions, indirect populations, and unavailable triangulation tools.
- **Contradictions:** evidence differs by intervention bundle and outcome; combined monitoring + consultation should not be equated with device-only telemonitoring.
- **Confidence reasoning:** ordinal, dimension-based, with explicit penalties rather than false precision.
- **Provenance:** claim-to-source and downstream inference/hypothesis/innovation/validation/decision edges are now representable.
- **Saudi applicability:** Saudi context is not treated as effectiveness evidence; local descriptive evidence remains separate from global causal evidence.
- **Innovation opportunity:** the research logic supports testing human-in-the-loop remote monitoring / nurse-led transitional care rather than assuming device-only monitoring is effective.
- **Validation plan:** prospective, outcome-defined evaluation with pre-specified readmission/mortality endpoints and implementation measures; clinical/regulatory review remains human.
- **Human decision gate:** Go/No-Go, clinical and regulatory conclusions remain recommendations requiring human approval.

## Readiness ladder

| Level | Status | Evidence |
|---|---|---|
| **FOUNDATION** | **PASS** | Research protocol, evidence discipline, source hierarchy, Saudi and red-team governance already existed in PR #3. |
| **RESEARCH-PROTOTYPE** | **PASS** | Executable adapters registry, bounded state machine, canonical ledger model, confidence engine, provenance graph, human gates, validators and tests are now present. |
| **PILOT-READY** | **NOT YET** | Requires observed CI pass, at least one real adapter implementation with repeatable health checks, a second independent host/runtime proving contract portability, full-text evidence path, and a reproducible E2E harness. |
| **PRODUCTION-READY** | **NO** | Requires security/privacy review, dependency and supply-chain controls, durable state/audit storage, operational monitoring, authenticated tool execution, failure recovery, clinical/regulatory governance, and production validation. |

## Hard constraints respected

- No new PR created.
- PR #3 branch updated directly.
- `index.html` was not modified by the hardening commits.
- No tool availability was inferred from configuration or name.
- No new external research result was invented.
- No clinical or regulatory authority was assigned to the agent.

## Bottom line

**The architecture is now executable at the runtime-contract level, but the research intelligence layer is still partly prompt-governed and the external-tool adapters are host-dependent. Classification: RESEARCH-PROTOTYPE.**
